2023 GAPNA Annual Conference
Industry-Supported Presentation Theaters and Symposia


Wednesday, September 27, 2023

Supported by Sumitomo Pharma America, Inc.4:30 – 6:30 pm
(Dinner will be provided)
Overactive Bladder Bootcamp: Update on Current Treatment Approaches
Presenters: Jeffrey Frankel, MD; Diane Newman, DNP, CRNP, FAAN, BCB-PMD
This program will discuss the unique role of advanced practice nurses in the management of urology conditions in older adults, specifically lower urinary tract symptoms; review opportunities for improving overactive bladder symptom recognition and strategies for managing care using challenging patient cases; and share best practices and insights on addressing compliance challenges, the use of telemedicine, and addressing communication gaps related to OAB management in older adults.
Supported by Sumitomo Pharma America, Inc.
Room location: Celestin BC

Thursday, September 28, 2023

12:30 pm – 1:30 pm
(Lunch will be provided)
Industry-Supported Presentation Theaters

Supported by Sumitomo Pharma America, Inc.Discover the Impact of GEMTESA, An Effective OAB Treatment: A Fresh Look at OAB Management in Long-Term Care Settings
Presenter: Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
GEMTESA is a β3-adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.
Supported by Sumitomo Pharma America, Inc.
Room location: Celestin BC

Supported by Neurocrine Biosciences, Inc.The Impact of TD in LTC: Recognizing and Treating Tardive Dyskinesia in Long-Term Care
Moderator: Todd Leland
Speaker: Amber R. Hoberg, PMHNP

Older patients and residents with tardive dyskinesia require special considerations. Learn about symptoms, prevalence, and management guidelines for TD in this population. Faculty will share clinical data for an FDA-approved treatment option for adults with tardive dyskinesia and highlight
first-of-its-kind data from a post hoc analysis of safety and efficacy for adults aged 65 years and older. Participants will also be able to examine the case of a real patient with tardive dyskinesia by observing videos of the patient before and after treatment.
Supported by Neurocrine Biosciences, Inc.
Room location: Celestin GH

6:30 pm – 8:00 pm
(Dinner will be provided)
Industry-Supported Presentation Theater
Supported by Otsuka America Pharmaceutical, Inc. & LundbeckAgitation Associated with Dementia Due to Alzheimer’s Disease: Experts Discuss Treatment Considerations and Current Guidelines
Presenters: Meenakshi Patel, MD, FACP, MMM, CMD; Cristi Bundakamara, EdD, PMHNP-BC
This program will highlight the importance of engaging patients and caregivers in discussions about agitation associated with Alzheimer's dementia. In addition, the audience will review case studies involving hypothetical caregivers and patients with agitation associated with Alzheimer’s dementia, illustrating the importance of collaboration in diagnosing and managing patients. Finally, the audience will review the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer’s disease.
Supported by Otsuka America Pharmaceutical, Inc. & Lundbeck
Room location: Celestin BC

Friday, September 29, 2023

7:00 am – 8:00 am
MedEdicus, LLC Breakfast Symposium

Supported by MedEdicus, LLCParkinson’s Disease Psychosis: Managing Complex Patients with Behavioral Manifestations
Presenters: Fay Bembry, MSN, RN, FNP-BC, PMHNP-BC; Susan Scanland, MSN, CRNP, GNP-BC, CDP, CSP
Parkinson’s disease psychosis (PDP), particularly with behavioral manifestations is a complex debilitating condition that needs early identification and treatment with non-pharmacologic and pharmacologic interventions. Advanced practice nurses (NP) are at the forefront of managing and coordinating care for these patients, especially in the long-term care setting. The focus of this case-based activity is for NPs to become more adept at identifying PDP and develop person-centered non-pharmacologic and pharmacologic management plans for older adults with PDP who exhibit behavioral disturbances.
Supported by MedEdicus, LLC
*Contact hours awarded by sponsor.
Room location: Celestin BC

12:00 pm – 1:00 pm
(Lunch will be provided)
Industry-Supported Presentation Theaters

Supported by Smith&Nephew   Implementing Customized Wound Treatment Plans for the Complex Patient
Moderator: Kristina Tiskowitz, MSN, RN, CWS
Presenter: Amy Bruggemann, MSN, APRN-BC, CWS

The T.I.M.E. principles of wound bed preparation in the management of chronic wounds describe using Tissue, Infection, Moisture, and Edge as the framework. T.I.M.E. offers a systemic approach to wound healing by eliminating the necrosis, controlling the inflammation or infection, restoring the proper moisture balance, and promoting epithelial edge advancement. Join us for this educational event where you will learn how to decide the right treatment at the right time utilizing the T.I.M.E. clinical decision support tool.
Supported by Smith&Nephew   
Room location: Celestin BC

IDgenetix PGx Testing Can Help Guide Neuropsychiatric Medication Selection and Management for Older Adults
Presenter: Raymond A. Lorenz, PharmD, BCPP
IDgenetix PGxPharmacogenomic (PGx) testing has been shown to improve patient outcomes in multiple therapeutic areas and patient types, including older adults who are more likely to experience polypharmacy, inappropriate medication use, and adverse effects. Multiple factors must be considered when managing older adults’ medication regimens, such as comorbidities, concurrent medications, and lifestyle factors. IDgenetix assesses drug-gene interactions, drug-drug interactions, and drug-lifestyle interactions to generate an actionable report that can help clinicians choose medications that are not only genetically appropriate, but also clinically appropriate. This presentation will review the evidence supporting the use of IDgenetix in older adult populations.
Supported by Castle Biosciences
Room location: Celestin GH

5:45 pm – 7:00 pm
(Dinner will be provided)
Industry-Supported Presentation Theater
Supported by Eisai, Inc.Preparing for a Shift in Alzheimer’s Disease Management
Presenters: Susan Scanland, MSN, CRNP, GNP-BC, CDP; Susan Steen, MD
Please join us as distinguished faculty provide their insights on the evolving diagnostic and treatment landscape in Alzheimer’s disease (AD) care. The speakers will offer their perspectives on the patient journey and role of advanced practice nurses (APNs) in AD care through topics including: diagnostic workflow changes utilizing traditional and novel clinical tools, including during referral; increasing the workforce to detect early stages of AD; assessment patient appropriateness and implementation of potential disease-modifying treatments (DMTs); and appropriate safety monitoring of DMTs. Overall, this session aims to provide perspective to APNs for the adoption of the evolving AD treatment landscape.
Supported by Eisai, Inc.
Room location: Celestin BC